Is a complete WVE research report available?

No complete published report is available for Wave Life Sciences Ltd. (WVE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Wave Life Sciences Ltd. (WVE)

NASDAQ: WVE · USD

$5.81

+0.03 (+0.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first WVE analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.1B
Revenue (ttm)	71.8M
Net income (ttm)	-183.6M
EPS (ttm)	-$1.03
Shares out	192.4M
Volume	2,067,115
Beta	-1.30
Price target	$21.9	+277.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 71.8M
Net income (ttm): -183.6M
EPS (ttm): -$1.03
Market cap: 1.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All WVE indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001631574
Company name	Wave Life Sciences Ltd.
Country	Singapore
Country code	US
Cusip	Y95308105
Employees	317
Employees Change	29%
Employees Change Percent	10.07
Enterprise value	$589M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-11-11
Isin	SG9999014716
Last refreshed	2026-07-25
Market cap	$1.1B
Market cap category	Small-Cap
Price	$5.81
Price currency	USD
Rev Per Employee	226,492.11x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	WVE
Website	https://wavelifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.42%
EV Sales Forward	27.49x
EV/Sales	8.2x
FCF yield	-16.55%
P/B ratio	2.18x
P/S ratio	15.57x
PS Forward	52.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-274.21%
EBITDA Margin	-269.47%
Gross margin	-164.07%
Gross Profit	$-117.8M
Net Income	$-183.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-255.7%
Profit Margin	-255.7%
Profit Per Employee	$-579,139
ROA	-28.23
Roa5y	-31.91
ROCE	-36.89
ROE	-53.11
Roe5y	-2,338.2
ROIC	-33.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-12.1%
Cagr1y	-32.14%
Cagr3y	10.9%
Cagr5y	-0.1%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-31.58x
Revenue Growth Q	316.85x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	69.18x
Revenue Growth5 Y	35.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.16
Assets	$583.5M
Cash	$544.6M
Current Assets	$561.3M
Current Liabilities	$49.8M
Debt	$15.7M
Debt Equity	$0.03
Equity	$511.7M
Liabilities	$71.8M
Long Term Assets	$22.3M
Long Term Liabilities	$22M
Net Cash	$528.9M
Net Cash By Market Cap	$47.31
Net Cash Growth	140.97%
Net Debt Equity	$-1.03
Tangible Book Value	$511.7M
Tangible Book Value Per Share	$2.66
WACC	-2.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.26
Net Working Capital	$-24.8M
Quick ratio	10.93
Working Capital	$511.4M
Working Capital Turnover	$0.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.45%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-72.46%
1Y total return	-32.13%
200-day SMA	9.65
3Y total return	36.39%
50-day SMA	6.07
50-day SMA vs 200-day SMA	50under200
5Y total return	-0.51%
All Time High	56
All Time High Change	-89.63%
All Time High Date	2018-09-24
All Time Low	1.16
All Time Low Change	400.86%
All Time Low Date	2022-05-13
ATR	0.28
Beta	-1.3
Beta1y	1.47
Beta2y	2.12
Ch YTD	-65.82
High	5.89
High52	21.73
High52 Date	2025-12-09
High52ch	-73.26%
Low	5.74
Low52	5.02
Low52 Date	2026-03-26
Low52ch	15.74%
Ma50ch	-4.22%
Premarket Change Percent	1.21
Premarket Price	$5.85
Premarket Volume	31,811
Price vs 200-day SMA	-39.78%
RSI	44.89
RSI Monthly	44.87
RSI Weekly	36.2
Sharpe ratio	0.32x
Sortino ratio	0.84
Total Return	-21.45%
Tr YTD	-65.82
Tr1m	-3.81%
Tr1w	-0.17%
Tr3m	-20.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	16
Analyst Count Top	9
Analyst Price Target Top	$26.88
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.3
Earnings Revenue Estimate	7,396,424x
Earnings Revenue Estimate Growth	-14.97x
Operating Income	$-196.9M
Operating margin	-274.2
Price target	$21.94
Price Target Change	$278
Price Target Change Top	$363

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	90,119,028%
Float Percent	46.84%
Shares Insiders	0.38%
Shares Institutions	62.66%
Shares Out	192,402,202
Shares Qo Q	11.11%
Shares Yo Y	21.45%
Short Float	23.19%
Short Ratio	5.97
Short Shares	10.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-214.1M
Average Volume	2,638,675.65x
Bv Per Share	2.66
CAPEX	$-991,000
Ch10y	-72.46
Ch1m	-3.81
Ch1w	-0.17
Ch1y	-32.13
Ch3m	-20.52
Ch3y	36.39
Ch5y	-0.51
Ch6m	-56.87
Change	0.52%
Change From Open	0.17
Close	5.78
Days Gap	0.35
Depreciation Amortization	3,406,000
Dollar Volume	12,009,938.2
Earnings Date	2026-07-30
Earnings Time	bmo
EBIT	$-196.9M
EBITDA	$-193.5M
EPS	$-1.03
F Score	1
FCF	$-185M
FCF EV Yield	-31.41x
FCF Per Share	$-0.96
Financing CF	486,607,000
Fiscal Year End	December
Founded	2,012
Investing CF	-991,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	9.86
Ma150ch	-41.08%
Ma20	5.96
Ma20ch	-2.57%
Net CF	301,559,000
Next Earnings Date	2026-07-30
Open	5.8
Optionable	Yes
Position In Range	46.67
Post Close	5.81
Postmarket Change Percent	0.31
Postmarket Price	$5.83
Ppne	18,071,000
Pre Close	5.78
Price Date	2026-07-24
Ptbv Ratio	2.18
Relative Volume	0.78x
Revenue	71,798,000x
SBC By Revenue	40.51x
Share Based Comp	29,083,000
Tr6m	-56.87%
Volume	2,067,115
Z Score	10.22

Wave Life Sciences Ltd. (WVE)

Coverage state: Market snapshot only — no published research

Generate the first WVE analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · WVE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All WVE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on WVE

Frequently asked questions